Skip to content
10-Q

Quarterly Report

MEDRESPONSE CORP.

0001477932-17-004708

← back to feed
Filed
Sep 25, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Sep 25, 2017 9.56M sh
Operating Cash Flow Q1 2017 · Mar 31, 2017 −$4.04K
Operating Cash Flow Q1 2017 · Mar 31, 2016 −$84
Cash And Equivalents Q1 2017 · Mar 31, 2017 $820
Cash And Equivalents Q1 2017 · Dec 31, 2016 $862
Cash And Equivalents Q1 2017 · Mar 31, 2016 $16
Cash And Equivalents Q1 2017 · Dec 31, 2015 $100
Stockholders Equity Q1 2017 · Mar 31, 2017 −$30.95K
Stockholders Equity Q1 2017 · Dec 31, 2016 −$27.6K
Current Liabilities Q1 2017 · Mar 31, 2017 $31.77K
Current Liabilities Q1 2017 · Dec 31, 2016 $28.47K
Total Liabilities Q1 2017 · Mar 31, 2017 $31.77K
Total Liabilities Q1 2017 · Dec 31, 2016 $28.47K
Current Assets Q1 2017 · Mar 31, 2017 $820
Current Assets Q1 2017 · Dec 31, 2016 $862
Total Assets Q1 2017 · Mar 31, 2017 $820
Total Assets Q1 2017 · Dec 31, 2016 $862
Net Income Q1 2017 · Mar 31, 2017 −$3.34K
Net Income Q1 2017 · Mar 31, 2016 −$7.31K
Operating Income Q1 2017 · Mar 31, 2017 −$3.34K
Operating Income Q1 2017 · Mar 31, 2016 −$6.97K